{
  "4PC.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MED.IMAG.AI",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "5V7.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "8CT.F": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CANNABIX TECHS INC.",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "9MH.F": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "MedX Health Corp",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDX HEALTH CORP.",
    "state": "ON",
    "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
    "website": "http://www.medxhealth.com",
    "zipcode": "L5T 1M2"
  },
  "ASAPF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Aurora Spine Corporation",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AURORA SPINE CORPORATION",
    "state": "ON",
    "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.aurora-spine.com",
    "zipcode": "M4S 3B1"
  },
  "ASG.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Aurora Spine Corporation",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AURORA SPINE CORPORATION",
    "state": "ON",
    "summary": "Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. It also provides pain care services. The company was incorporated in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.aurora-spine.com",
    "zipcode": "M4S 3B1"
  },
  "ASTI.CN": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Aquarius Surgical Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "AquariusSurgTe",
    "state": "ON",
    "summary": "Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., manufactures, distributes, services, supports, and trains laser systems and consumables in various medical disciplines in Canada and the United States. Its products include Pathfinder laser for the treatment of benign prostate hyperplasia; HYPHO laser to treat urinary stone; Versafine FRx laser to address vaginal health related conditions associated with menopause; and ASTI's surgical lasers for supporting wavelengths and medical procedures. The company also offers clinical education, service, support, and maintenance services. The company was formerly known as Aquarius Coatings Inc. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.",
    "website": "http://aquariussurgical.com",
    "zipcode": "M5R 1G4"
  },
  "B3BN.F": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP.",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "B3BN.MU": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP.",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "BLO.CN": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CannabixTech",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "BLOZF": {
    "city": "Burnaby",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cannabix Technologies Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CANNABIX TECHNOLOGIES INC",
    "state": "BC",
    "summary": "Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.",
    "website": "http://www.cannabixtechnologies.com",
    "zipcode": "V5A 4R4"
  },
  "CRRVF": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "CVM.V": {
    "city": "North Vancouver",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "CVR Medical Corp.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CVR MEDICAL CORP",
    "state": "BC",
    "summary": "CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. The company was formerly known as Big Bar Resources Corporation and changed its name to CVR Medical Corp. in September 2016. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.",
    "website": "http://cvrmed.com",
    "zipcode": "V7M 3J3"
  },
  "DPD3.F": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGIN MEDICAL INC.",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "FLURF": {
    "city": "Calgary",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "FluroTech Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "FLUROTECH LTD",
    "state": "AB",
    "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
    "website": "http://www.flurotech.com",
    "zipcode": "T2L 1Y1"
  },
  "G5Z3.F": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NEOVASC INC.",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "IDL.V": {
    "city": "Vaughan",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Imaging Dynamics Company Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGING DYNAMICS COMPANY LTD",
    "state": "ON",
    "summary": "Imaging Dynamics Company Ltd., a medical technology company, provides digital radiography equipment worldwide. The company offers imaging detectors; and flat panel detectors under Aquarius8600 and VetnovaXion names. It also provides Magellan, a medical image processing software; and Sirius, a veterinary image processing software. In addition, the company provides 1600 Plus X-Series, a DR solution with a floor mounted U-arm multi-axis positioning device that includes X-ray tube, collimator, and generator; and veterinary DR systems. Further, it provides after sales services. It offers products through dealers, distributors, and original equipment manufacturer partners. The company was formerly known as Imaging Dynamics Corporation and changed its name to Imaging Dynamics Company Ltd. in October 2001. Imaging Dynamics Company Ltd. was founded in 1995 and is headquartered in Vaughan, Canada.",
    "website": "http://www.imagingdynamics.com",
    "zipcode": "L4K 4P3"
  },
  "IME.CN": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ImaginMedical",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "IMEXF": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Imagin Medical Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "IMAGIN MEDICAL INC",
    "state": "BC",
    "summary": "Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",
    "website": "http://imaginmedical.com",
    "zipcode": "V6C 1L9"
  },
  "JNX.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC.",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "LXGTF": {
    "city": "Vancouver",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Registered Plan Private Investments Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LEXINGTON BIOSCIENCES INC",
    "state": "BC",
    "summary": "Lexington Biosciences, Inc. does not have significant operations. Previously, it was engaged in the development and commercialization of non-invasive diagnostic products for cardiovascular health. The company is headquartered in Vancouver, Canada.",
    "website": "http://www.lexingtonbiosciences.com",
    "zipcode": "V6E 2E9"
  },
  "MDX.V": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "MedX Health Corp",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "MEDX HEALTH CORP",
    "state": "ON",
    "summary": "MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. It offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, a research system used to assess treatment effectiveness of a variety of skin conditions, including burns. The company operates DermSecure telemedicine platform that enables the web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. In addition, it designs, manufactures, and distributes photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.",
    "website": "http://www.medxhealth.com",
    "zipcode": "L5T 1M2"
  },
  "NVCN": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NMS",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Neovasc Inc.",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "NVCN.TO": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Neovasc Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NEOVASC INC",
    "state": "BC",
    "summary": "Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, Canada, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",
    "website": "http://www.neovasc.com",
    "zipcode": "V6V 2J7"
  },
  "ORTH.CN": {
    "city": "Kirkland",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Ortho Regenerative Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OrthoRegenTech",
    "state": "QC",
    "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
    "website": "http://www.orthorti.com",
    "zipcode": "H9H 4R9"
  },
  "ORTIF": {
    "city": "Kirkland",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Ortho Regenerative Technologies Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ORTHO REGENERATIVE TECHNOLOGIES",
    "state": "QC",
    "summary": "Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair. It also develops Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.",
    "website": "http://www.orthorti.com",
    "zipcode": "H9H 4R9"
  },
  "PINK.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MEDICAL IMAGING AI IN",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "PMED.CN": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "CNQ",
    "industry": "Medical Devices",
    "long_name": "Predictmedix Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PredictmedixInc",
    "state": "ON",
    "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.predictmedix.com",
    "zipcode": "M5K 1G8"
  },
  "PMEDF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Predictmedix Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "PREDICTMEDIX INC",
    "state": "ON",
    "summary": "Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for healthcare screenings and impairment detection. The company's AI products use facial, thermal, video, and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease, or mental illness. It also focuses on developing AI based screening, such as COVID19 solutions for the healthcare industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.predictmedix.com",
    "zipcode": "M5K 1G8"
  },
  "PROF": {
    "city": "Mississauga",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Profound Medical Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "Profound Medical Corp.",
    "state": "ON",
    "summary": "Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.",
    "website": "http://www.profoundmedical.com",
    "zipcode": "L4W 5K5"
  },
  "PSH.DE": {
    "city": "London",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "de_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "PSH.F": {
    "city": "London",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "PYNKF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Perimeter Medical Imaging AI, Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "PERIMETER MEDICAL IMAGING AI IN",
    "state": "ON",
    "summary": "Perimeter Medical Imaging AI, Inc., a clinical stage medical device company, develops, patents, and commercializes advanced in-procedural medical imaging tools. The company offers an optical tissue imaging system, an imaging platform, which provides clinicians with the real time ability to assess tissue microstructures during diagnostic, surgical, and pathology procedures. The company was founded in 2013 and is headquartered in Toronto, Canada.",
    "website": "http://www.perimetermed.com",
    "zipcode": "M5E 1E6"
  },
  "QTNA.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "TITAN MEDICAL INC.",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "SEOVF": {
    "city": "London",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORPORATION",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "SVA.V": {
    "city": "London",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Sernova Corp.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SERNOVA CORP.",
    "state": "ON",
    "summary": "Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.",
    "website": "http://www.sernova.com",
    "zipcode": "N6G 4X8"
  },
  "TEST.V": {
    "city": "Calgary",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "FluroTech Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "FLUROTECH LTD",
    "state": "AB",
    "summary": "FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the cannabis and hemp industries. It engages in the commercialization and sale of CompleTest, a portable cannabis and hemp testing device that provides cannabis and hemp testing results when used with FluroTech's specialty test kits. The company also engages in developing and commercializing a biotracker technology for cannabis and hemp seed to sale tracking. FluroTech Ltd. has a strategic agreement with Alberta BioPhotonics Inc. and Albany Medical College. The company is headquartered in Calgary, Canada.",
    "website": "http://www.flurotech.com",
    "zipcode": "T2L 1Y1"
  },
  "THRBF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "THRM.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Therma Bright Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "THERMA BRIGHT INC",
    "state": "ON",
    "summary": "Therma Bright Inc. develops and markets thermal therapy technology that provides topical relief to skin irritations resulting from insect bites, stings, and prevention of cold sores. It offers InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. The company was incorporated in 2001 and is based in Toronto, Canada.",
    "website": "http://thermabright.com",
    "zipcode": "M4M 3P1"
  },
  "TLT.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIES INC.",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "TLTFF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIES INC",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "TMD.TO": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "TOR",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "ca_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "TITAN MEDICAL INC",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "TMDI": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NCM",
    "industry": "Medical Devices",
    "long_name": "Titan Medical Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Titan Medical Inc.",
    "state": "ON",
    "summary": "Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada.",
    "website": "http://www.titanmedicalinc.com",
    "zipcode": "M5H 3B7"
  },
  "TTX.F": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Theralase Technologies Inc.",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "THERALASE TECHNOLOGIE.INC",
    "state": "ON",
    "summary": "Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.",
    "website": "http://www.theralase.com",
    "zipcode": "M4B 3G4"
  },
  "VERO": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "NGM",
    "industry": "Medical Devices",
    "long_name": "Venus Concept Inc.",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Venus Concept Inc.",
    "state": "ON",
    "summary": "Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.",
    "website": "http://www.venusconcept.com",
    "zipcode": "M2J 4Y8"
  },
  "VPT.V": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "CAD",
    "exchange": "VAN",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "ca_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "VPTDF": {
    "city": "Toronto",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "VentriPoint Diagnostics Ltd.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VENTRIPOINT DIAGNOSTICS LTD",
    "state": "ON",
    "summary": "Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System, a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is headquartered in Toronto, Canada.",
    "website": "http://www.ventripoint.com",
    "zipcode": "M2N 5Y7"
  },
  "VRSEF": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Verisante Technology Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VERISANTE TECHNOLOGY INC",
    "state": "BC",
    "summary": "Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.",
    "website": "http://www.verisante.com",
    "zipcode": "V6V 3B7"
  },
  "VRSYF": {
    "city": "Ottawa",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "VMS Rehab Systems, Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "VMS REHAB SYSTEMS",
    "state": "ON",
    "summary": "VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products. The company also sells orthopedic wedge seat cushions for relieving the discomfort and/or pain caused by other lower body medical issues, including pilonidal disease, piles disease, and hemorrhoids to home healthcare retail networks in Canada. VMS Rehab Systems, Inc. was founded in 1998 and is based in Ottawa, Canada.",
    "website": "http://www.vmsrehabsystemsinc.com",
    "zipcode": "K1R 7X6"
  },
  "ZMSPF": {
    "city": "Richmond",
    "country": "Canada",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Zecotek Photonics Inc.",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ZECOTEK PHOTONICS INC",
    "state": "BC",
    "summary": "Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. The company operates through three divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Its imaging systems include lutetium fine silicate scintillation crystals; solid-state micro-pixel avalanche photo diode photo detectors and transistors; and integrated detector modules. The company also develops glasses-free 3D displays; and 3D auto-stereoscopic displays, and 3D printers and related technologies. The company was formerly known as Zecotek Medical Systems Inc. and changed its name to Zecotek Photonics Inc. in November 2007. Zecotek Photonics Inc. was incorporated in 1983 and is headquartered in Richmond, Canada.",
    "website": "http://www.zecotek.com",
    "zipcode": "V6W 0A5"
  }
}
